United States· US:64764-253_2346b7f5-b2c1-45f0-9f8f-5cbb4b202857
OSENI
A medicinal product containing alogliptin benzoate; pioglitazone hydrochloride, registered in United States by Takeda Pharmaceuticals America, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
- Manufacturer
- Takeda Pharmaceuticals America, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc11647642530330 TABLET, FILM COATED in 1 BOTTLE (64764-253-03)
- ndc11647642530490 TABLET, FILM COATED in 1 BOTTLE (64764-253-04)
- ndc116476425305500 TABLET, FILM COATED in 1 BOTTLE (64764-253-05)
- ndc1164764-253-03
- ndc1164764-253-04
- ndc1164764-253-05
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Alogliptin benzoate; pioglitazone hydrochloride in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e52291d3-a332-41cd-910a-51111d74d1d8 GET /v1/drugs/e52291d3-a332-41cd-910a-51111d74d1d8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "25; 30",
"substance": "ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE",
"productndc": "64764-253",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1; mg/1",
"application_number": "NDA022426",
"marketing_category": "NDA"
}See everything about alogliptin benzoate; pioglitazone hydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.